Please assess the completion status of the following clinical trial:

Trial Title: Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women during one of their first 3 IVF cycle attempts~* Women between the ages of 18-42.~* BMI (body mass index) of 18-35.~* AMH (Anti mullerian hormone) \> 1 ng/ml~* FSH˂ 20 IU/L.~* Informed consent.~Exclusion Criteria:~* Women with low ovarian response~* Previous enrollment in this study.~* AFC\>20~* E2 above 15,000 pmol/l at the trigger day.~* hypersensitive to Suprefact/Pregny/gonal F/Purigon/Menopur/progesterone, and/or their ingredients/components of the formulation~* primary ovarian failure~* pregnancy and breast-feeding~* active blood clots~* undiagnosed uterine or genital bleeding~* endometriosis~* uncontrolled hypertension;~* uncontrolled diabetes~* abnormal liver and kidney functions~* abnormal ECG, e.g. QT prolongation and torsades de pointes~* cancers/tumors, e.g. pituitary adenomas, ovarian cysts, etc.~* HIV, HBV and HCV infections~* low bone mineral density (BMD) and an increased risk of bone fracture, such as chronic alcohol and/or tobacco use, presumed or strong family history of osteoporosis or chronic use of drugs that can reduce bone mass such as anticonvulsants or corticosteroids~* suicidal tendency, history or disposition to seizures, state of confusion, clinically relevant psychiatric disorders, and brain lesions~* Use of an investigational drug or participation in an investigational study within 30 days prior to this study.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 41 Years
- Healthy Volunteers: t

Study Arms:
- Double trigger (Type: EXPERIMENTAL): Triggering of ovulation with GnRH agonist ( Suprefact 0.5mg) + hCG ( Pregnyl 10,000IU)
- control (Type: PLACEBO_COMPARATOR): Triggering of ovulation with hCH ( Pregnyl 10,000IU) + Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).